Arvinas Inc reports results for the quarter ended June 30 - Earnings Summary

Arvinas

04/08/2026 14:31

Arvinas Inc ARVN.OQ reported quarterly adjusted earnings of $2.58​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -84 cents.  The mean expectation of fourteen analysts for the quarter was for a loss of 37 cents per share. Wall Street expected results to range from $-1.04 to $1.26 per share.
Revenue rose 1,014.7% to $249.70 million from a year ago; analysts expected $32.54 million. 
Arvinas Inc's reported EPS for the quarter was $2.58​.
The company reported quarterly net income of $169.4 million.
Arvinas Inc shares had fallen by 3.0% this quarter and lost 32.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 55.4% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Arvinas Inc is $15.50, about 48% above its last closing price of $8.06
This summary was machine generated from LSEG data August 4 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.37
2.58
Beat
Mar. 31 2026 
-0.92
-0.90
Beat
Dec. 31 2025 
-0.59
-1.10
Missed
Sep. 30 2025 
-0.79
-0.48
Beat